Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study

Background/Aim: Mumps is by vaccine preventable infectious disease characterised by parotitis. In India mumps vaccines are not currently used under National Immunisation Programme (NIP). Waning of vaccine-induced immunity is considered to play a central role in the re-emergence of mumps. The compreh...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gupta Riya, Saxena Naveen, Gupta Parul
Formato:	article
Lenguaje:	EN SR
Publicado:	Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine 2021
Materias:	antibody measles mumps vaccination Medicine R
Acceso en línea:	https://doaj.org/article/83220977f27d46eba77ec20e22fc580f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:83220977f27d46eba77ec20e22fc580f
record_format	dspace
spelling	oai:doaj.org-article:83220977f27d46eba77ec20e22fc580f2021-12-05T21:31:53ZDetermination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study2490-33292303-795410.5937/scriptamed52-33074https://doaj.org/article/83220977f27d46eba77ec20e22fc580f2021-01-01T00:00:00Zhttps://scindeks-clanci.ceon.rs/data/pdf/2490-3329/2021/2490-33292103174G.pdfhttps://doaj.org/toc/2490-3329https://doaj.org/toc/2303-7954Background/Aim: Mumps is by vaccine preventable infectious disease characterised by parotitis. In India mumps vaccines are not currently used under National Immunisation Programme (NIP). Waning of vaccine-induced immunity is considered to play a central role in the re-emergence of mumps. The comprehensive data on the seroepidemiology of measles, mumps, and rubella (MMR) as well as studies which compare the antibody titre among mumps vaccine naiveand mumps vaccinated children are lacking. The aim of this study was to estimate and compare mumps specific antibody titre in children with and without MMR vaccine. Methods: In 2019/2020, blood samples were collected from 100 healthy children attending immunisation clinic in Government Medical College Kota and associated J K Lon Maternal and Child care hospital Kota. The samples were investigated for MMR IgG antibodies using ELISA. Results: Out of total 100 children included in the study, 32.27 % vaccinated and 4.83 % non-vaccinated children were positive for mumps IgG antibody in the age group of 6 months to 6 years of age. Children aged 6 to 12 years, vaccinated and non-vaccinated, had 31.57 % and 26.57 % positivity, respectively. The seroprevalence of measles, mumps and rubella antibodies among 50 MMR vaccinated children were 94 %, 64 %, and 96 %, respectively. A high measles and rubella seroprevalences were observed among all children age groups, suggesting an effective control program, while the mumps seroprevalence decreased significantly with age. Conclusion: The maximum vaccine effectiveness against mumps for 2 doses of MMR vaccine is ≈ 96 %. The herd immunity threshold to block mumps virus transmission is ≥ 86 %. In this study only 64 % of the vaccinated children were found to have IgG mumps antibodies. In view of morbidity following mumps infection there is a need to incorporate mumps vaccine along with measles and rubella vaccine in the NIP instead of Mr.Gupta RiyaSaxena NaveenGupta ParulMedical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of MedicinearticleantibodymeaslesmumpsvaccinationMedicineRENSRScripta Medica, Vol 52, Iss 3, Pp 174-180 (2021)
institution	DOAJ
collection	DOAJ
language	EN SR
topic	antibody measles mumps vaccination Medicine R
spellingShingle	antibody measles mumps vaccination Medicine R Gupta Riya Saxena Naveen Gupta Parul Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study
description	Background/Aim: Mumps is by vaccine preventable infectious disease characterised by parotitis. In India mumps vaccines are not currently used under National Immunisation Programme (NIP). Waning of vaccine-induced immunity is considered to play a central role in the re-emergence of mumps. The comprehensive data on the seroepidemiology of measles, mumps, and rubella (MMR) as well as studies which compare the antibody titre among mumps vaccine naiveand mumps vaccinated children are lacking. The aim of this study was to estimate and compare mumps specific antibody titre in children with and without MMR vaccine. Methods: In 2019/2020, blood samples were collected from 100 healthy children attending immunisation clinic in Government Medical College Kota and associated J K Lon Maternal and Child care hospital Kota. The samples were investigated for MMR IgG antibodies using ELISA. Results: Out of total 100 children included in the study, 32.27 % vaccinated and 4.83 % non-vaccinated children were positive for mumps IgG antibody in the age group of 6 months to 6 years of age. Children aged 6 to 12 years, vaccinated and non-vaccinated, had 31.57 % and 26.57 % positivity, respectively. The seroprevalence of measles, mumps and rubella antibodies among 50 MMR vaccinated children were 94 %, 64 %, and 96 %, respectively. A high measles and rubella seroprevalences were observed among all children age groups, suggesting an effective control program, while the mumps seroprevalence decreased significantly with age. Conclusion: The maximum vaccine effectiveness against mumps for 2 doses of MMR vaccine is ≈ 96 %. The herd immunity threshold to block mumps virus transmission is ≥ 86 %. In this study only 64 % of the vaccinated children were found to have IgG mumps antibodies. In view of morbidity following mumps infection there is a need to incorporate mumps vaccine along with measles and rubella vaccine in the NIP instead of Mr.
format	article
author	Gupta Riya Saxena Naveen Gupta Parul
author_facet	Gupta Riya Saxena Naveen Gupta Parul
author_sort	Gupta Riya
title	Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study
title_short	Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study
title_full	Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study
title_fullStr	Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study
title_full_unstemmed	Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study
title_sort	determination of elisa reactive mumps igg antibodies in mmr vaccine recipients in comparison with mmr vaccine naive children: a cross sectional study
publisher	Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine
publishDate	2021
url	https://doaj.org/article/83220977f27d46eba77ec20e22fc580f
work_keys_str_mv	AT guptariya determinationofelisareactivemumpsiggantibodiesinmmrvaccinerecipientsincomparisonwithmmrvaccinenaivechildrenacrosssectionalstudy AT saxenanaveen determinationofelisareactivemumpsiggantibodiesinmmrvaccinerecipientsincomparisonwithmmrvaccinenaivechildrenacrosssectionalstudy AT guptaparul determinationofelisareactivemumpsiggantibodiesinmmrvaccinerecipientsincomparisonwithmmrvaccinenaivechildrenacrosssectionalstudy
_version_	1718370954174791680

Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study

Ejemplares similares